Navigation Links
WuXi AppTec Welcomes Three Senior Professionals
Date:3/24/2009

SHANGHAI, March 24 /PRNewswire-Asia/ -- WuXi AppTec (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of three key senior professionals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Brian J. Xu has joined WuXi AppTec as Vice President of Toxicology and Head of the Safety Evaluation Center at Suzhou, reporting to Dr. Ge Li, Chairman and Chief Executive Officer. Dr. Xu is an American Board Certified Toxicologist (DABT) and had worked previously in Merck, Roche, Schering-Plough and Enzon. Dr. Xu received his Ph.D. from George Washington University and did post-doctoral research at Yale University.

Dr. Yang-Dar Yuan has joined the company as Vice President of Operation and Head of Pathology of the Safety Evaluation Center, reporting to Dr. Brian Xu. Dr. Yuan is a member of American College of Veterinary Pathologists (ACVP), a member of the American College of Laboratory Animal Medicine and an American Board Certified Toxicologist (DABT). He brings more than 30 years of rich experiences in preclinical safety assessment and drug development. Dr. Yuan had worked previously in Upjohn, Pfizer, Allergan and Vitae Pharmaceutical. Dr. Yuan received a D.V.M. from National Taiwan University and a Ph.D. in Veterinary Pathology from Cornell University.

Mr. Robert Coldreck has joined the company as Head of GLP (Good Laboratory Practice) QA (Quality Assurance). Mr. Coldreck had previously worked in Novartis, most recently as Director of Laboratory and Preclinical Quality Assurance-North America and Asia. He brings more than 30 y
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WuXi PharmaTech to Acquire AppTec Laboratory Services, Inc.
2. WuXi PharmaTech Completes Acquisition of AppTec
3. WuXi AppTec VP and GM Invited to Join the AAMI Standards Board
4. WuXi AppTec Appoints Garry Takle, Ph.D. as VP of Operations and Joseph Hughes, Ph.D. as VP of Testing Services for Philadelphia Facility
5. WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation
6. Professor K. C. Nicolaou Speaks at WuXi AppTec
7. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
8. Start Licensing, Inc. Welcomes FDAs Finding of Safety of Food From Cloned Animals
9. BioSpace Career Fair in San Francisco Welcomes Over 1,000 Bioscience Professionals
10. FCP Welcomes Mark Scherling
11. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 01, 2015 Sistemic Ltd. and ... into a commercial collaboration agreement and signed a ... their technologies and work together towards advancing the ... RoosterBio and Sistemic will collaborate on utilizing microRNA ... more precise and relevant characterization panels for hMSC ...
(Date:6/1/2015)... 2015  Berg, a biopharmaceutical company committed to uncovering ... research from its trials using its cancer drug BPM ... on triple negative breast cancer, at the 51 st ... Oncology (ASCO), May 29 – June 2 in ... is one of the first cancer drugs guided in ...
(Date:6/1/2015)... Research and Markets( http://www.researchandmarkets.com/research/5j2hpk/2015_strategies ) ... "2015 Strategies in the US Point-of-Care/POC Clinical ... This new 373-page report contains ... of the POC clinical chemistry market, including ... trends, competitive landscape, and emerging opportunities for ...
(Date:6/1/2015)... 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced positive, new, long-term ... of AST-VAC1 in patients with intermediate and high ... Company,s autologous (using cells sourced from the patient) ... most common form of acute leukemia in adults ...
Breaking Biology Technology:Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 2Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 3Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 4Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 2Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 3Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 4Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 5Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 6Positive New, Long-Term Follow-Up Data of Asterias Biotherapeutics' AST-VAC1 Cancer Vaccine Demonstrates Prolonged Relapse-Free Survival in Patients with High-Risk Acute Myelogenous Leukemia (AML) 7
... is effective when ... applications and vaccines, ANN ARBOR, Mich., Oct. 21 ... new data in nine presentations that,detail key milestones in ... cystic fibrosis and an intra-nasal,influenza vaccine during the joint ...
... FRAZER, Pa. and PHILADELPHIA, Oct. 21 ,Cephalon, Inc. ... EURX ) today announced,receipt of a Paragraph ... an Abbreviated New Drug Application (ANDA) submitted to ... Pharmaceuticals, Inc.,requesting approval to market and sell a ...
... Heart, Inc. announced,today that five patients have received ... important early milestone in the U.S.,Pivotal Trial. A ... five implants,at the University of Michigan Cardiovascular Center ... off-pump., "We congratulate Dr. Pagani on conducting ...
Cached Biology Technology:NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008 2Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 2Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 3Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules 4Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial 2
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
(Date:4/20/2015)... , April 20, 2015 ...   Glenbeigh Records Management (GRM), Ireland,s ... with Dubai Islamic Bank. Having built up an impressive track ... now a leading player within the records management sector in ... expects to double is GCC staffbase and employ a further ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
... news release is available in German . ... son. Evolutionary biologists at the universities in Bielefeld (Germany) and Uppsala ... a long life at least for fruit flies ( Drosophila ... mostly inherit their lifespan from their own sex: male descendants will ...
... international schemes that allow payments to landholders for planting ... sequestration of carbon from the atmosphere. But they will ... food supply problems, if other benefits and disbenefits from ... in land-use decisions, according to an article published in ...
... peat bogs and other previously unexpected environments are ... methylmercury, researchers at Oak Ridge National Laboratory and ... This finding, published in Environmental Science and ... produced in areas where the neurotoxin,s presence has ...
Cached Biology News:Inheritance of lifespan is sex-dependent in fruit flies 2Toxic methylmercury-producing microbes more widespread than realized 2